Talis Biomedical Corporation

Talis Biomedical Corporation is a molecular diagnostic company based in Chicago, Illinois. Founded in 2013, the company went public on February 12, 2021, and trades on the OTC Markets under the ticker symbol TLIS. Talis Biomedical specializes in developing medical devices for infectious diseases, focusing on molecular diagnostic tests that can be administered at the point of care. The company has a team of 99 employees and is led by CEO Robert Kelley. Currently, Talis Biomedical is exploring various strategic alternatives for its future direction.